Skip to content

Matthew A. Albrecht

3 papers in the library · publishing 2021-2025

Papers

Sort Most recent Most cited

The effect of a synthetic cannabinoid agonist (nabilone) on unimodal tactile illusion correlates with a psychometric scores in healthy volunteers

Scientific Reports May 27, 2025 Faiz Mohammed Kassim, Alexander J. W. Davey, Sophie Tod et al.

Our previous studies showed that dexamphetamine, an indirect dopamine agonist, widens Stimulus Binding Windows (BWs) in healthy subjects. The present study aimed to investigate the effect of nabilone, a synthetic cannabinoid agonist, on the BWs in a unimodal illusion: the tactile funneling illusion (TFI). The study also aimed to study the association between tactile illusion with psychometric...

Nabilone Impairs Spatial and Verbal Working Memory in Healthy Volunteers.

Cannabis and Cannabinoid Research February 1, 2024 Faiz M Kassim, Sophie Tod, Jennifer Rodger et al.

Background: Memory impairments and psychosis-like experiences can be adverse effects of cannabis use. However, reports on the cognitive impact of cannabis use are not consistent. There are also limited studies on the psychotomimetic effects of cannabinoid compounds to reveal the association between cannabis and psychosis. Therefore, we investigated the effect of acute cannabinoid intoxication...

A Systematic Review of the MDMA Model to Address Social Impairment in Autism.

Current Neuropharmacology 2021 Devahuti Chaliha, John C Mamo, Matthew A. Albrecht et al.

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterised by repetitive behaviours, cognitive rigidity/inflexibility, and social-affective impairment. Unfortunately, no gold-standard treatments exist to alleviate the core socio-behavioural impairments of ASD. Meanwhile, the prosocial empathogen/entactogen 3,4-methylene-dioxy-methamphetamine (MDMA) is known to enhance...